Zelira Therapeutics Upholds Strong Corporate Governance

Zelira Therapeutics (AU:ZLD) has released an update.

Zelira Therapeutics Limited has affirmed its commitment to corporate governance in line with ASX guidelines, disclosing that its practices are fully compliant throughout the reported period. The company’s governance statement and board charter details are accessible on their website, ensuring transparency for shareholders and stakeholders. The statement, current as of 28 August 2024, is board-approved and can be found at https://zeliratx.com/corporate-governance/

For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.